project id: TCGA-SKCM; case submitter id: TCGA-ER-A196; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.76; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.3; rna integrity number: 9.7; age at index: 64; days to birth: -23533; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1943; age at diagnosis: 23533; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1785.0; icd 10 code: C44.7; last known disease status: not reported; morphology: 8744/3; primary diagnosis: Acral lentiginous melanoma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1106; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-ER-A196-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 85.0;